Market Tracker

12/19 11:01pm ET

Oragenics Inc (NYSE MKT LLC:OGEN)

1.03
Data as of Dec 19
 -0.07 / -6.36%
Today’s Change
0.74
Today|||52-Week Range
4.65
-63.35%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close1.10
Today’s open1.05
Day’s range1.02 - 1.24
Volume22,152
Average volume (3 months)33,648
Market cap$37.3M
Dividend yield--
Data as of 3:58pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+33.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-22.49%
P/E ratioNM
Price/Sales78.34
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...-0.12-2.98%
GNVCGenVec Inc+0.25+12.82%
ANTHAnthera Pharmaceutic...-0.12-7.06%
SKBISkystar Bio-Pharmace...-0.06-1.45%
Data as of 4:00pm ET, 12/19/2014

Financials

Last reporting dateDecember 22, 2014
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.0M
Annual profit (last year)-$16.1M
Net profit margin-1,556.70%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Secretary &
Treasurer
Michael O'Keefe Sullivan
Senior Vice President-
Discovery Research
Martin Handfield
Corporate headquarters
Tampa, Florida

Forecasts